The 84-year-old Kentucky Republican is back in Washington after a fall, hospitalization, pneumonia and weeks of rehabilitation kept him away from the Senate.
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.